Literature DB >> 7759599

Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.

A Jewett1, B Bonavida.   

Abstract

Natural killer (NK) cells play an important role in host defense mechanisms against infection and neoplasia. Interferon-alpha (IFN-alpha) has been shown to activate NK cells and to augment their cytotoxic activity, albeit its role in the maturation pathway of NK cells has not been elucidated. The present study examined whether IFN-alpha activates the immature NK subset (Free cells) to become cytotoxic and also ascertained whether IFN-alpha uses the same pathway of activation as that mediated by interleukin-2 (IL-2). Incubation of sorted Free cells overnight with IFN-alpha resulted in augmentation of their cytotoxic function against NK sensitive target cells. The enhanced cytotoxic activity was not accompanied by a new recruitment of NK-target binder cells but by an increase in the frequency of killer cells in the conjugate fraction. Activation of the Free subset by IFN-alpha resulted in upregulation of CD69, CD11b, and CD2 surface expression and stimulated secretion of IFN-gamma. Unlike IL-2, IFN-alpha did not stimulate the Free cells to proliferate or secrete TNF-alpha and activation of cytotoxicity and modulation of surface antigens by IFN-alpha were independent of TNF-alpha. The failure of IFN-alpha to stimulate secretion and proliferation by Free cells appeared to be mediated by negative signals. This was corroborated in experiments demonstrating that when Free cells were cultured with both IFN-alpha and IL-2, a significant inhibition was observed for both the IL-2 dependent secretion of TNF-alpha and proliferation. These results demonstrate that IFN-alpha serves as both an activator and a regulator of NK function. Further, activation of the immature Free NK cells by IL-2 and IFN-alpha proceeds by TNF-alpha- dependent and independent pathways, respectively. The findings also support our contention that the mechanism of activation of the cytotoxic machinery of NK cells is not linked to the mechanism of activation of cytokine secretion and/or proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759599     DOI: 10.1007/BF01489488

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18).

Authors:  L Di Renzo; E Yefenof; E Klein
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

Review 2.  Regulation of natural killer activity.

Authors:  J R Ortaldo
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis.

Authors:  A Silva; B Bonavida; S Targan
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

4.  Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.

Authors:  S C Wright; A Jewett; R Mitsuyasu; B Bonavida
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

5.  Cytotoxic in vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy. Effects of activation with recombinant interleukin-2.

Authors:  C Feruglio; R Zambello; L Trentin; P Bulian; T Franceschi; G L Cetto; G Semenzato
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

6.  The proliferation and life-span of rat large granular lymphocytes: effects of cytokines.

Authors:  J T Vaage; C W Reynolds; D Reynolds; S Fossum; B Rolstad
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

Review 7.  Protein kinase C and T cell activation.

Authors:  N Berry; Y Nishizuka
Journal:  Eur J Biochem       Date:  1990-04-30

8.  Functional characteristics of the intercellular adhesion molecule-1 (CD54) expressed on cytotoxic human blood lymphocytes.

Authors:  P Wang; F Vánky; S L Li; M Patarroyo; E Klein
Journal:  Cell Immunol       Date:  1990-12       Impact factor: 4.868

9.  Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo.

Authors:  M T Kasaian; C A Biron
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

10.  Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.

Authors:  M J Robertson; R J Soiffer; S F Wolf; T J Manley; C Donahue; D Young; S H Herrmann; J Ritz
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Immunotherapy for renal carcinoma: theoretical basis and current standard of care.

Authors:  P A Vasey
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

2.  Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.

Authors:  Anna K Kozlowska; Han-Ching Tseng; Kawaljit Kaur; Paytsar Topchyan; Akihito Inagaki; Vickie T Bui; Noriyuki Kasahara; Nicholas Cacalano; Anahid Jewett
Journal:  Cancer Immunol Immunother       Date:  2016-07-20       Impact factor: 6.968

3.  Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells.

Authors:  Abena K R Kwaa; Chloe A G Talana; Joel N Blankson
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects.

Authors:  Emmanouil Papasavvas; Livio Azzoni; Andrew V Kossenkov; Noor Dawany; Knashawn H Morales; Matthew Fair; Brian N Ross; Kenneth Lynn; Agnieszka Mackiewicz; Karam Mounzer; Pablo Tebas; Jeffrey M Jacobson; Jay R Kostman; Louise Showe; Luis J Montaner
Journal:  J Immunol       Date:  2019-06-28       Impact factor: 5.422

5.  Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells.

Authors:  Nathan Simon; Antonella Antignani; Stephen M Hewitt; Massimo Gadina; Christine Alewine; David FitzGerald
Journal:  JCI Insight       Date:  2019-03-07

6.  Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells.

Authors:  Han-Ching Tseng; Aida Arasteh; Avina Paranjpe; Antonia Teruel; Wendy Yang; Armin Behel; Jackelyn A Alva; Gina Walter; Christian Head; Tomo-o Ishikawa; Harvey R Herschman; Nicholas Cacalano; April D Pyle; No-Hee Park; Anahid Jewett
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

7.  Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs.

Authors:  Kawaljit Kaur; Paytsar Topchyan; Anna Karolina Kozlowska; Nick Ohanian; Jessica Chiang; Phyu Ou Maung; So-Hyun Park; Meng-Wei Ko; Changge Fang; Ichiro Nishimura; Anahid Jewett
Journal:  Oncoimmunology       Date:  2018-02-22       Impact factor: 8.110

8.  Strategies to rescue mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) from NK cell mediated cytotoxicity.

Authors:  Anahid Jewett; Aida Arasteh; Han-Ching Tseng; Armin Behel; Hobie Arasteh; Wendy Yang; Nicholas A Cacalano; Avina Paranjpe
Journal:  PLoS One       Date:  2010-03-31       Impact factor: 3.240

9.  Impaired interferon signaling is a common immune defect in human cancer.

Authors:  Rebecca J Critchley-Thorne; Diana L Simons; Ning Yan; Andrea K Miyahira; Frederick M Dirbas; Denise L Johnson; Susan M Swetter; Robert W Carlson; George A Fisher; Albert Koong; Susan Holmes; Peter P Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

10.  N-acetylcysteine protects dental pulp stromal cells from HEMA-induced apoptosis by inducing differentiation of the cells.

Authors:  Avina Paranjpe; Nicholas A Cacalano; Wyatt R Hume; Anahid Jewett
Journal:  Free Radic Biol Med       Date:  2007-07-20       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.